144 related articles for article (PubMed ID: 2870353)
1. Double-blind, placebo-controlled study of luteinising-hormone-releasing-hormone nasal spray in treatment of undescended testes.
deMuinck Keizer-Schrama SM; Hazebroek FW; Matroos AW; Drop SL; Molenaar JC; Visser HK
Lancet; 1986 Apr; 1(8486):876-80. PubMed ID: 2870353
[TBL] [Abstract][Full Text] [Related]
2. LH-RH nasal spray treatment for cryptorchidism. A double-blind, placebo-controlled study.
De Muinck Keizer-Schrama SM; Hazebroek FW; Drop SL; Molenaar JC; Visser HK
Eur J Pediatr; 1987; 146 Suppl 2():S35-7. PubMed ID: 2891518
[TBL] [Abstract][Full Text] [Related]
3. [Undescended testis treated by intranasal application of luteinizing hormone-releasing hormone (LH-RH)].
Rasmussen TB; Kristensen ES; Gandrup P; Ingerslev HJ
Ugeskr Laeger; 1991 Feb; 153(9):640-3. PubMed ID: 1672569
[TBL] [Abstract][Full Text] [Related]
4. Hormonal therapy of cryptorchidism. A randomized, double-blind study comparing human chorionic gonadotropin and gonadotropin-releasing hormone.
Rajfer J; Handelsman DJ; Swerdloff RS; Hurwitz R; Kaplan H; Vandergast T; Ehrlich RM
N Engl J Med; 1986 Feb; 314(8):466-70. PubMed ID: 2868413
[TBL] [Abstract][Full Text] [Related]
5. Management of the non-descended testis: doubtful value of luteinizing-hormone-releasing-hormone (LHRH). A double-blind, placebo-controlled multicentre study.
Olsen LH; Genster HG; Mosegaard A; Jørgensen FS; Hofman N; Jensen VB; Lassen LB; Rassmussen M; Vinzents L; Dammegaard L
Int J Androl; 1992 Apr; 15(2):135-43. PubMed ID: 1349301
[TBL] [Abstract][Full Text] [Related]
6. Primary gonadotropin releasing hormone and adjunctive human chorionic gonadotropin treatment in cryptorchidism: a clinical trial.
Nane I; Ziylan O; Esen T; Kocak T; Ander H; Tellaloglu S
Urology; 1997 Jan; 49(1):108-11. PubMed ID: 9000196
[TBL] [Abstract][Full Text] [Related]
7. Luteinising hormone-releasing hormone nasal spray as therapy for undescended testicle.
Pirazzoli P; Zappulla F; Bernardi F; Villa MP; Aleksandrowicz D; Scandola A; Stancari P; Cicognani A; Cacciari E
Arch Dis Child; 1978 Mar; 53(3):235-8. PubMed ID: 25629
[TBL] [Abstract][Full Text] [Related]
8. Success and relapse rate after treatment of cryptorchidism with intranasal LHRH.
Schwarz HP; Aebi S; Perisic M
Acta Paediatr Scand; 1985 Mar; 74(2):274-80. PubMed ID: 2859731
[TBL] [Abstract][Full Text] [Related]
9. Luteinising hormone releasing hormone for incomplete descent of the testis.
Klidjian AM; Swift PG; Johnstone JM
Arch Dis Child; 1985 Jun; 60(6):568-71. PubMed ID: 2861791
[TBL] [Abstract][Full Text] [Related]
10. Success, relapse and failure after intranasal LHRH treatment of cryptorchidism in 55 prepubertal boys.
Illig R; Bucher H; Prader A
Eur J Pediatr; 1980 Mar; 133(2):147-50. PubMed ID: 6102517
[TBL] [Abstract][Full Text] [Related]
11. Treatment of cryptorchidism with human chorionic gonadotropin or gonadotropin releasing hormone. A double-blind controlled study of 243 boys.
Christiansen P; Müller J; Buhl S; Hansen OR; Hobolth N; Jacobsen BB; Jørgensen PH; Kastrup KW; Nielsen K; Nielsen LB
Horm Res; 1988; 30(4-5):187-92. PubMed ID: 2907896
[TBL] [Abstract][Full Text] [Related]
12. Combined therapy with LHRH and HCG in cryptorchid infants.
Lala R; Matarazzo P; Chiabotto P; de Sanctis C; Canavese F; Hadziselimovic F
Eur J Pediatr; 1993; 152 Suppl 2():S31-3. PubMed ID: 8101810
[TBL] [Abstract][Full Text] [Related]
13. Treatment of cryptorchidism by intranasal synthetic luteinising-hormone releasing hormone. Results of a collaborative double-blind study.
Illig R; Exner GU; Kollmann F; Kellerer K; Borkenstein M; Lunglmayr L; Kuber W; Prader A
Lancet; 1977 Sep; 2(8037):518-20. PubMed ID: 95729
[TBL] [Abstract][Full Text] [Related]
14. Hormonal treatment of cryptorchidism--hCG or GnRH--a multicentre study.
Christiansen P; Müller J; Buhl S; Hansen OR; Hobolth N; Jacobsen BB; Jørgensen PH; Kastrup KW; Nielsen K; Nielsen LB
Acta Paediatr; 1992 Aug; 81(8):605-8. PubMed ID: 1356527
[TBL] [Abstract][Full Text] [Related]
15. Effect of LHRH treatment on testicular descent and hormonal response in cryptorchidism.
Wit JM; Delemarre-Van de Waal HA; Bax NM; Van den Brande JL
Clin Endocrinol (Oxf); 1986 May; 24(5):539-48. PubMed ID: 2878745
[TBL] [Abstract][Full Text] [Related]
16. [Effects of gonadoliberin administered nasally in cryptorchidism in aged 1 to 6].
Job JC; Joab N; Safar A; Canlorbe P
Arch Fr Pediatr; 1987 Feb; 44(2):91-5. PubMed ID: 2883952
[TBL] [Abstract][Full Text] [Related]
17. Early hormonal and surgical treatment of cryptorchidism.
Lala R; Matarazzo P; Chiabotto P; Gennari F; Cortese MG; Canavese F; de Sanctis C
J Urol; 1997 May; 157(5):1898-901. PubMed ID: 9112559
[TBL] [Abstract][Full Text] [Related]
18. Effect of intranasal LHRH therapy on plasma LH, FSH and testosterone, and relation to clinical results in prepubertal boys with cryptorchidism.
Illig R; Torresani T; Bucher H; Zachmann M; Prader A
Clin Endocrinol (Oxf); 1980 Jan; 12(1):91-7. PubMed ID: 6103766
[TBL] [Abstract][Full Text] [Related]
19. [LH-RH nasal spray (Kryptocur), a new aspect in the hormonal treatment of undescended testes (author's transl)].
Zabransky S
Klin Padiatr; 1981 Sep; 193(5):382-4. PubMed ID: 6116818
[TBL] [Abstract][Full Text] [Related]
20. [The medical treatment of cryptorchism in early childhood].
Lala R; Canavese F; Matarazzo P; Chiabotto P; De Sanctis C
Pediatr Med Chir; 1991; 13(1):73-5. PubMed ID: 1675784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]